| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |